Breathing Easier: MIR and Keva Health Partner to Transform Asthma Care

Breathing Easier: MIR and Keva Health Partner to Transform Asthma Care

Asthma affects more than 25 million Americans, leading to nearly 1.8 million emergency room visits and 170,000 hospital stays each year. For respiratory therapists, pulmonologists, and healthcare teams, the challenge is clear: episodic, in-clinic pulmonary function testing is not enough to prevent dangerous flare-ups. Patients need continuous respiratory monitoring and clinicians need reliable, actionable spirometry data they can trust.

That’s exactly what the partnership between MIR (Medical International Research) and Keva Health is delivering through remote patient monitoring (RPM) for asthma management.

The Partnership in Action

At Baystate Health in Massachusetts, a peer-reviewed pilot study demonstrated how remote spirometry and RPM technology could improve outcomes for patients with moderate to severe asthma.

• Patients were equipped with MIR’s Spirobank Smart, a Bluetooth-enabled, ATS/ERS-compliant handheld spirometer, along with pulse oximeters.
• These devices connected to Keva Health’s KevaTalk app and Keva365 digital health platform, allowing patients to log daily lung function, asthma symptoms, and medication use directly from home.
• Data automatically flowed to physicians and care teams, enabling them to identify concerning trends in lung function and intervene earlier.

For RTs and clinicians, this meant receiving real-time spirometry metrics such as FEV1, FVC, and peak expiratory flow (PEF) without waiting weeks or months for a follow-up appointment.

Measurable Results from the Study

• 1,155 remote spirometry sessions completed over 3 months.
• 92% patient compliance with daily asthma check-ins.
• 484 clinical alerts were generated, with 37% requiring physician or RT review.
• Escalations led to medication adjustments, targeted patient education, and prevented ER visits.

Importantly, all patients produced usable home spirometry data, proving that with proper instruction, patients can perform reliable pulmonary function testing at home.

Why This Matters for Respiratory Care Teams

For respiratory therapists and healthcare professionals, this care model offers clear advantages:

• Better clinical decision-making: Continuous spirometry and oximetry provide a more complete picture than occasional in-office PFTs.
• Exacerbation prevention: Early detection of declining ung function enables interventions before an emergency occurs.
• Patient empowerment: Daily RPM check-ins increase adherence to asthma action plans and strengthen the RT–patient relationship.
• Seamless workflow integration: Keva365 generates real-time RPM reports that can be reviewed during telehealth or in-person visits.
• Reimbursement support: Remote spirometry and RPM services are reimbursable through CMS CPT codes (99453, 99454, 99457, 99458), creating a sustainable model for providers and health systems.

Patient Voices and Physician Insights

Patients consistently reported that the RPM solution was simple, reliable, and confidence-building. One participant even described the platform as “like having my doctor in my pocket.”

Physicians and RTs noted the ability to:

• Track adherence to asthma action plans.
• Detect green, yellow, and red zone peak flow values in real time.
• Intervene early to reduce hospitalizations and improve patient outcomes.

Supporting Evidence from Keva Health Publications

The Baystate Health pilot is part of a growing body of evidence demonstrating Keva Health’s impact in digital respiratory care:

• Impact of Remote Patient Monitoring Platform on Patients With Moderate to Severe Persistent Asthma – Peer-reviewed study in JMIR Formative Research, showing high engagement, reduced exacerbations, and potential healthcare cost savings.
• Effects of Remote Patient Monitoring on Patients Prescribed Biologic Medications – AAAAI 2024 abstract highlighting how RPM supported asthma patients on biologics, reducing symptom days and enabling faster physician intervention.
• Patient Engagement on a Remote Therapeutic Monitoring Program for Chronic Disease Management of Asthma – AAAAI 2024 abstract demonstrating high patient satisfaction (NPS 80) and over 1,000 spirometry readings recorded in 7 months.

Together, these studies validate how connected spirometry and remote monitoring improve patient outcomes, clinician workflow, and healthcare efficiency.

The Future of Respiratory Care

The MIR–Keva Health partnership demonstrates the shift from episodic care to continuous, connected respiratory management. With MIR’s evidence-based spirometry devices and Keva’s innovative RPM platform, clinicians can deliver:

• Better outcomes for asthma patients
• Reduced hospital utilization and long-term cost savings
• Stronger engagement and adherence across respiratory care

As RTs and providers expand their role in chronic disease management, connected spirometry and remote patient monitoring are proving to be practical, scalable tools for improving both care quality and patient quality of life.

Learn more about MIR’s respiratory care solutions and spirometry devices at usa.spirometry.com.